carboxymethyl-dextran-A2-gadolinium-DOTA

Known as: CMD-A2-Gd-DOTA 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2016
01219972016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A study was conducted to determine the effects of feeding sorghum distiller's dried grains with solubles (SDDGS) on carcasses… (More)
Is this relevant?
2011
2011
Mutations in LMNA cause a variety of diseases affecting striated muscle including autosomal Emery-Dreifuss muscular dystrophy… (More)
  • figure 1
  • figure 2
  • table 2
  • table 2
  • figure 3
Is this relevant?
2011
2011
In this study, photoswitchable microcapsules were fabricated based on host-guest interactions between α-cyclodextrin (α-CD) and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Life-threatening cardiac and respiratory complications are common in LMNA-related myopathies and early diagnosis is important for… (More)
  • figure 1
  • figure 2
Is this relevant?
2004
2004
We have previously reported that sialylglycopeptide (SGP) and its derivatives isolated from egg yolk had a preventive effect on… (More)
Is this relevant?
2001
2001
The objective of this study was to assess two new slow-clearance contrast media with extracellular and intravascular distribution… (More)
Is this relevant?
2000
2000
Recent developments in magnetic resonance imaging (MRI) using specific contrast media allow the assessment of myocardial… (More)
Is this relevant?
1999
1999
The purpose of this study was to assess the ability of the new blood pool contrast agent meglumine-carboxymethyldextran… (More)
Is this relevant?
1999
1999
Meglumine-carboxymethyldextran-ethylenediamino-gadoterate (CMD-A2-Gd-DOTA) was evaluated as a blood pool contrast agent for… (More)
Is this relevant?
1997
1997
PURPOSE We investigated the synthesis and physical, chemical and biological characterisation of a carboxymethyl-dextran polymer… (More)
Is this relevant?